Business
VENTANA BIOTECH INC. – SHAREHOLDER UPDATE
VENTANA BIOTECH INC. SHAREHOLDER UPDATE
About this update from Vanta Holdings Inc.
[{"type":"text","content":"\nVENTANA BIOTECH INC. – SHAREHOLDER UPDATE\n\n\n Jul. 23, 2009 (TheNewswire.ca) -- Ventana Biotech Inc (\"Ventana\")(VNTA.PK), a biotechnology company that is developing a ground breaking appetite-suppressing chewing gum, today announced that after nearly 3 months preparation and work, the Company received \"Current Disclosure\" status, the highest possible on the Pink OTC Markets (see www.pinksheets.com ).We are committed to provide complete transparency for our shareholders and potential investors. Our goal, by the end of the year, is to file for registration with the OTC Bulletin Board. This will increase the opportunity to broaden our exposure to potential investors so we can advance our business plan and create more value for our early investors.Furthermore, Ventana is pleased to announce that our appetite suppressing chewing gum for the treatment of obesity, hypertension and metabolic disorders, is now under 2nd stage review by the European patent office. We will provide a further updates on this review in due course.Finally, the Company has recently signed a Memorandum of Understanding with a new industry partner for collaboration on identifying new targets as well as collaboration on future distribution and royalty agreements. A formal announcement will be made upon execution of a definitive agreement. This agreement will open up exciting opportunities for advancement of our business plan.About Ventana Biotech Inc (OOTC:VNTA) Ventana is positioning itself as the leading bioscience company in the development and commercial licensure of novel therapeutic anti-obesity drug treatment. The company leverages cutting-edge research collaborations to achieve breakthroughs in innovative anti-obesity treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies.FORWARD-LOOKING STATEMENTS:Statements about Ventana's future expectations and all other statements in this press release other than historical facts are \"forward-looking statements\" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. Ventana's actual results could differ materially from expected results. Ventana does not undertake any obligation to update forward-looking stat...